DNM1L and neoplasm: Inhibition of Drp1 through therapeutic treatment with mdivi-1, a specific Drp1 inhibitor, resulted in significant decrease in murine tumor growth, providing additional support the importance of mitochondrial fission in cancer survival and proliferation [30].